Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Mankin

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Cancer Letters|February 11, 2010
Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcomaZhenfeng Duan, Diana Ji, Edward J Weinstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2010
Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancerYuqi Guo, Jeffrey Nemeth, Colin O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferationZhenfeng Duan, Jianming Zhang, Edwin Choy, et al.
Oncotarget|April 15, 2015
Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordomaYong Feng, Jacson Shen, Yan Gao, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 22, 2015
Clinical and biological significance of PIM1 kinase in osteosarcomaYunfei Liao, Yong Feng, Jacson Shen, et al.
International Journal of Nanomedicine|May 2, 2015
Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cellsLinlin Zhang, Arun K Lyer, Xiaoqian Yang, et al.
Plos One|June 4, 2010
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcomaMichiro Susa, Arun K Iyer, Keinosuke Ryu, et al.
Carcinogenesis|January 1, 2010
The kinase Mirk is a potential therapeutic target in osteosarcomaCao Yang, Diana Ji, Edward J Weinstein, et al.
Blood Cells, Molecules & Diseases|June 18, 2002
Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapyRaphael Schiffmann, Henry Mankin, James M Dambrosia, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 31, 2009
Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expressionZhenfeng Duan, Edwin Choy, G Petur Nielsen, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Cancer Letters|February 11, 2010
Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcomaZhenfeng Duan, Diana Ji, Edward J Weinstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2010
Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancerYuqi Guo, Jeffrey Nemeth, Colin O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferationZhenfeng Duan, Jianming Zhang, Edwin Choy, et al.
Oncotarget|April 15, 2015
Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordomaYong Feng, Jacson Shen, Yan Gao, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 22, 2015
Clinical and biological significance of PIM1 kinase in osteosarcomaYunfei Liao, Yong Feng, Jacson Shen, et al.
International Journal of Nanomedicine|May 2, 2015
Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cellsLinlin Zhang, Arun K Lyer, Xiaoqian Yang, et al.
Plos One|June 4, 2010
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcomaMichiro Susa, Arun K Iyer, Keinosuke Ryu, et al.
Carcinogenesis|January 1, 2010
The kinase Mirk is a potential therapeutic target in osteosarcomaCao Yang, Diana Ji, Edward J Weinstein, et al.
Blood Cells, Molecules & Diseases|June 18, 2002
Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapyRaphael Schiffmann, Henry Mankin, James M Dambrosia, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 31, 2009
Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expressionZhenfeng Duan, Edwin Choy, G Petur Nielsen, et al.
Pageof 6